Make America Healthy Again Fails True Functional Medicine

Key Takeaways

• 60% of Americans have at least one chronic disease.
• Ultra‑processed foods supply >55% of daily calories, 62% for kids.
• MAHA supports glyphosate production despite anti‑pesticide origins.
• Measles cases surged to 2,200 in 2025, 1,136 early 2026.
• Functional medicine stresses root‑cause; MAHA ignores social determinants.

Pulse Analysis

America’s chronic disease burden has reached a tipping point, with six in ten adults living with at least one long‑term condition and more than half of daily calories derived from ultra‑processed products. These foods, linked by Lancet research to heart disease, diabetes, and early mortality, thrive in a food system skewed by commodity subsidies, lax GRAS approvals, and school‑lunch contracts that prioritize cost over nutrition. The resulting health crisis strains the health‑care system, inflates spending, and deepens socioeconomic inequities, making a comprehensive policy response essential.

Make America Healthy Again capitalizes on this urgency but delivers a fragmented agenda. While the movement correctly flags the dangers of processed foods, it paradoxically backs a Defense Production Act order to boost glyphosate‑based herbicide output—a stark reversal of its anti‑pesticide origins. Simultaneously, MAHA‑aligned groups resist stricter measles‑vaccination mandates even as cases climb to historic levels, undermining herd immunity. These contradictions dilute public‑health credibility and risk entrenching the very exposures the campaign claims to combat.

Functional medicine offers a counterpoint by insisting on root‑cause analysis that integrates diet, circadian timing, microbiome health, and socioeconomic context. Practitioners advocate for affordable whole‑food access, robust vaccine coverage, and policies that address food deserts and Medicaid cuts—elements absent from MAHA’s platform. By aligning clinical evidence with systemic reforms, functional medicine provides a roadmap for reducing chronic disease prevalence, lowering health‑care costs, and fostering equitable health outcomes across the population.